Skip to main content
Erschienen in: World Journal of Pediatrics 6/2018

28.08.2018 | Original Article

Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq

verfasst von: Hannah M. Phelps, Mazin F. Al-Jadiry, Natasha M. Corbitt, Janene M. Pierce, Bingshan Li, Qiang Wei, Raina R. Flores, Hernan Correa, Stefania Uccini, Haydar Frangoul, Adel R. Alsaadawi, Safaa A. F. Al-Badri, Amir F. Al-Darraji, Raghad M. Al-Saeed, Salma A. Al-Hadad, Harold N. Lovvorn III

Erschienen in: World Journal of Pediatrics | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Wilms tumor (WT) is the most common childhood kidney cancer worldwide, yet its incidence and clinical behavior vary according to race and access to adequate healthcare resources. To guide and streamline therapy in the war-torn and resource-constrained city of Baghdad, Iraq, we conducted a first-ever molecular analysis of 20 WT specimens to characterize the biological features of this lethal disease within this challenged population.

Methods

Next-generation sequencing of ten target genes associated with WT development and treatment resistance (WT1, CTNNB1, WTX, IGF2, CITED1, SIX2, p53, N-MYC, CRABP2, and TOP2A) was completed. Immunohistochemistry was performed for 6 marker proteins of WT (WT1, CTNNB1, NCAM, CITED1, SIX2, and p53). Patient outcomes were compiled.

Results

Mutations were detected in previously described WT “hot spots” (e.g., WT1 and CTNNB1) as well as novel loci that may be unique to the Iraqi population. Immunohistochemistry showed expression domains most typical of blastemal-predominant WT. Remarkably, despite the challenges facing families and care providers, only one child, with combined WT1 and CTNNB1 mutations, was confirmed dead from disease. Median clinical follow-up was 40.5 months (range 6–78 months).

Conclusions

These data suggest that WT biology within a population of Iraqi children manifests features both similar to and unique from disease variants in other regions of the world. These observations will help to risk stratify WT patients living in this difficult environment to more or less intensive therapies and to focus treatment on cell-specific targets.
Literatur
1.
Zurück zum Zitat Stiller CA, Parkin DM. International variations in the incidence of childhood renal tumours. Br J Cancer. 1990;62:1026–30.CrossRef Stiller CA, Parkin DM. International variations in the incidence of childhood renal tumours. Br J Cancer. 1990;62:1026–30.CrossRef
2.
Zurück zum Zitat Breslow N, Olshan A, Beckwith JB, Moksness J, Feigl P, Green D. Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor. J Natl Cancer Inst. 1994;86:49–51.CrossRef Breslow N, Olshan A, Beckwith JB, Moksness J, Feigl P, Green D. Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor. J Natl Cancer Inst. 1994;86:49–51.CrossRef
3.
Zurück zum Zitat Al-Hadad SA, Al-Jadiry MF, Al-Darraji AF, Al-Saeed RM, Al-Badr SF, Ghali HH. Reality of pediatric cancer in Iraq. J Pediatr Hematol Oncol. 2011;33:S154–6.CrossRef Al-Hadad SA, Al-Jadiry MF, Al-Darraji AF, Al-Saeed RM, Al-Badr SF, Ghali HH. Reality of pediatric cancer in Iraq. J Pediatr Hematol Oncol. 2011;33:S154–6.CrossRef
4.
Zurück zum Zitat Huff V. Wilms’ tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer. 2011;11:111–21.CrossRef Huff V. Wilms’ tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer. 2011;11:111–21.CrossRef
5.
Zurück zum Zitat Cancer Nusse R. Converging on beta-catenin in Wilms tumor. Science. 2007;316:988–9.CrossRef Cancer Nusse R. Converging on beta-catenin in Wilms tumor. Science. 2007;316:988–9.CrossRef
6.
Zurück zum Zitat Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, et al. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children’s Oncology Group Study. Neoplasia. 2012;14:742–56.CrossRef Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, et al. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children’s Oncology Group Study. Neoplasia. 2012;14:742–56.CrossRef
7.
Zurück zum Zitat Lovvorn HN, Westrup J, Opperman S, Boyle S, Shi G, Anderson J, et al. CITED1 expression in Wilms’ tumor and embryonic kidney. Neoplasia. 2007;9:589–600.CrossRef Lovvorn HN, Westrup J, Opperman S, Boyle S, Shi G, Anderson J, et al. CITED1 expression in Wilms’ tumor and embryonic kidney. Neoplasia. 2007;9:589–600.CrossRef
8.
Zurück zum Zitat Murphy AJ, Pierce J, de Caestecker C, Ayers GD, Zhao A, Krebs JR, et al. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus. Oncotarget. 2014;5:386–402.CrossRef Murphy AJ, Pierce J, de Caestecker C, Ayers GD, Zhao A, Krebs JR, et al. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus. Oncotarget. 2014;5:386–402.CrossRef
9.
Zurück zum Zitat Murphy AJ, Pierce J, de Caestecker C, Taylor C, Anderson JR, Perantoni AO, et al. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms’ tumor. J Pediatr Surg. 2012;47:1239–49.CrossRef Murphy AJ, Pierce J, de Caestecker C, Taylor C, Anderson JR, Perantoni AO, et al. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms’ tumor. J Pediatr Surg. 2012;47:1239–49.CrossRef
10.
Zurück zum Zitat Pode-Shakked N, Metsuyanim S, Rom-Gross E, Mor Y, Fridman E, Goldstein I, et al. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population. J Cell Mol Med. 2009;13:1792–808.CrossRef Pode-Shakked N, Metsuyanim S, Rom-Gross E, Mor Y, Fridman E, Goldstein I, et al. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population. J Cell Mol Med. 2009;13:1792–808.CrossRef
11.
Zurück zum Zitat Pierce J, Murphy AJ, Panzer A, de Caestecker C, Ayers GD, Neblett D, et al. SIX2 Effects on Wilms Tumor Biology. Transl Oncol. 2014;7:800–11.CrossRef Pierce J, Murphy AJ, Panzer A, de Caestecker C, Ayers GD, Neblett D, et al. SIX2 Effects on Wilms Tumor Biology. Transl Oncol. 2014;7:800–11.CrossRef
12.
Zurück zum Zitat Libes JM, Seeley EH, Li M, Axt JR, Pierce J, Correa H, et al. Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens. J Am Coll Surg. 2014;218:707–20.CrossRef Libes JM, Seeley EH, Li M, Axt JR, Pierce J, Correa H, et al. Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens. J Am Coll Surg. 2014;218:707–20.CrossRef
13.
Zurück zum Zitat Govender D, Harilal P, Hadley GP, Chetty R. p53 protein expression in nephroblastomas: a predictor of poor prognosis. Br J Cancer. 1998;77:314–8.CrossRef Govender D, Harilal P, Hadley GP, Chetty R. p53 protein expression in nephroblastomas: a predictor of poor prognosis. Br J Cancer. 1998;77:314–8.CrossRef
14.
Zurück zum Zitat Lahoti C, Thorner P, Malkin D, Yeger H. Immunohistochemical detection of p53 in Wilms’ tumors correlates with unfavorable outcome. Am J Pathol. 1996;148:1577–89.PubMedPubMedCentral Lahoti C, Thorner P, Malkin D, Yeger H. Immunohistochemical detection of p53 in Wilms’ tumors correlates with unfavorable outcome. Am J Pathol. 1996;148:1577–89.PubMedPubMedCentral
15.
Zurück zum Zitat Shaw AP, Poirier V, Tyler S, Mott M, Berry J, Maitland NJ. Expression of the N-myc oncogene in Wilms’ tumour and related tissues. Oncogene. 1988;3:143–9.PubMed Shaw AP, Poirier V, Tyler S, Mott M, Berry J, Maitland NJ. Expression of the N-myc oncogene in Wilms’ tumour and related tissues. Oncogene. 1988;3:143–9.PubMed
16.
Zurück zum Zitat Murphy AJ, Axt JR, de Caestecker C, Pierce J, Correa H, Seeley EH, et al. Molecular characterization of Wilms’ tumor from a resource-constrained region of sub-Saharan Africa. Int J Cancer. 2012;131:E983–94.CrossRef Murphy AJ, Axt JR, de Caestecker C, Pierce J, Correa H, Seeley EH, et al. Molecular characterization of Wilms’ tumor from a resource-constrained region of sub-Saharan Africa. Int J Cancer. 2012;131:E983–94.CrossRef
17.
Zurück zum Zitat McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.CrossRef McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.CrossRef
18.
Zurück zum Zitat Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213–9.CrossRef Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213–9.CrossRef
19.
Zurück zum Zitat Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucl Acids Res. 2010;38:e164.CrossRef Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucl Acids Res. 2010;38:e164.CrossRef
20.
Zurück zum Zitat Deng C, Dai R, Li X, Liu F. Genetic variation frequencies in Wilms’ tumor: a meta-analysis and systematic review. Cancer Sci. 2016;107:690–9.CrossRef Deng C, Dai R, Li X, Liu F. Genetic variation frequencies in Wilms’ tumor: a meta-analysis and systematic review. Cancer Sci. 2016;107:690–9.CrossRef
21.
Zurück zum Zitat Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, et al. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell. 2015;27:286–97.CrossRef Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM, et al. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell. 2015;27:286–97.CrossRef
22.
Zurück zum Zitat Wegert J, Ishaque N, Vardapour R, Georg C, Gu Z, Bieg M, et al. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell. 2015;27:298–311.CrossRef Wegert J, Ishaque N, Vardapour R, Georg C, Gu Z, Bieg M, et al. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell. 2015;27:298–311.CrossRef
23.
Zurück zum Zitat Lovvorn HN 3rd, Pierce J, Libes J, Li B, Wei Q, Correa H, et al. Genetic and chromosomal alterations in Kenyan Wilms Tumor. Genes Chromosomes Cancer. 2015;54:702–15.CrossRef Lovvorn HN 3rd, Pierce J, Libes J, Li B, Wei Q, Correa H, et al. Genetic and chromosomal alterations in Kenyan Wilms Tumor. Genes Chromosomes Cancer. 2015;54:702–15.CrossRef
24.
Zurück zum Zitat Takeuchi S, Bartram CR, Ludwig R, Royer-Pokora B, Schneider S, Imamura J, et al. Mutations of p53 in Wilms’ tumors. Mod Pathol. 1995;8:483–7.PubMed Takeuchi S, Bartram CR, Ludwig R, Royer-Pokora B, Schneider S, Imamura J, et al. Mutations of p53 in Wilms’ tumors. Mod Pathol. 1995;8:483–7.PubMed
25.
Zurück zum Zitat Beckwith JB, Zuppan CE, Browning NG, Moksness J, Breslow NE. Histological analysis of aggressiveness and responsiveness in Wilms’ tumor. Med Pediatr Oncol. 1996;27:422–8.CrossRef Beckwith JB, Zuppan CE, Browning NG, Moksness J, Breslow NE. Histological analysis of aggressiveness and responsiveness in Wilms’ tumor. Med Pediatr Oncol. 1996;27:422–8.CrossRef
26.
Zurück zum Zitat Graf N, van Tinteren H, Bergeron C, Pein F, van den Heuvel-Eibrink MM, Sandstedt B, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012;48:3240–8.CrossRef Graf N, van Tinteren H, Bergeron C, Pein F, van den Heuvel-Eibrink MM, Sandstedt B, et al. Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01. Eur J Cancer. 2012;48:3240–8.CrossRef
27.
Zurück zum Zitat Dome JS, Perlman EJ, Graf N. Risk stratification for wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014;34:215–23.CrossRef Dome JS, Perlman EJ, Graf N. Risk stratification for wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014;34:215–23.CrossRef
28.
Zurück zum Zitat Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, et al. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol. 2004;165:1943–53.CrossRef Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, et al. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol. 2004;165:1943–53.CrossRef
29.
Zurück zum Zitat Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer. 2008;47:461–70.CrossRef Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer. 2008;47:461–70.CrossRef
Metadaten
Titel
Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq
verfasst von
Hannah M. Phelps
Mazin F. Al-Jadiry
Natasha M. Corbitt
Janene M. Pierce
Bingshan Li
Qiang Wei
Raina R. Flores
Hernan Correa
Stefania Uccini
Haydar Frangoul
Adel R. Alsaadawi
Safaa A. F. Al-Badri
Amir F. Al-Darraji
Raghad M. Al-Saeed
Salma A. Al-Hadad
Harold N. Lovvorn III
Publikationsdatum
28.08.2018
Verlag
Childrens Hospital, Zhejiang University School of Medicine
Erschienen in
World Journal of Pediatrics / Ausgabe 6/2018
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-018-0181-3

Weitere Artikel der Ausgabe 6/2018

World Journal of Pediatrics 6/2018 Zur Ausgabe

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Durch übermäßige Internetnutzung wird oft die Schule verpasst

Häufige Fehlzeiten in der Schule können durch physische und psychische Probleme verursacht werden. Wie in einer Studie aus Finnland nun belegt wird, führt auch die exzessive Nutzung des Internets gehäuft zu Abwesenheiten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.